Shi, Y. ., Y. . Li, W. . Chen, M. . Zhang, D. . Qian, T. . Li, Y. . Dai, and G. . Li. “Cost-Effectiveness Analysis of Sintilimab Vs. Docetaxel As the Second-Line Therapy of Squamous Non-Small Cell Lung Cancer in China”. Health Decision, vol. 2, no. S1, July 2024, doi:10.54844/hd.2024.0007.